Castle Biosciences (CSTL) stock forecast for 2024

The forecast has been updated: May 13, 2022 9:14


Castle Biosciences stock price online today

Analyst Target Price

51.71

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell Castle Biosciences stock stock today? What is the projected target price level for 2024? How much will it cost in 2024? Castle Biosciences stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2024.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $51.71 target price for Castle Biosciences stock stock.

Today 200 Day Moving Average is the resistance level (49.65 $).

50 Day Moving Average is the resistance level (33.96 $).




CSTL Forecast for 2024

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 27.42 26.61 28.38 6.22 %
Feb 26.65 25.76 29.11 11.53 %
Mar 25.79 23.27 28.25 17.64 %
Apr 27.45 26.38 28.91 8.77 %
May 31.11 29.49 32.63 9.61 %
Jun 33.24 30.87 34.40 10.28 %
Jul 35.01 31.33 37.21 15.80 %
Aug 33.24 31.38 36.97 15.11 %
Sep 35.06 31.23 36.83 15.19 %
Oct 37.12 34.73 40.55 14.35 %
Nov 34.26 31.48 37.62 16.32 %
Dec 35.70 32.10 38.90 17.47 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Castle Biosciences stock.


Castle Biosciences overview

Castle Biosciences Address

820 S FRIENDSWOOD DRIVE, SUITE 201, FRIENDSWOOD, TX, US

Market Capitalization

475 123 000 $

EBITDA

5 935 000

PE Ratio

None

PEG Ratio

None

Dividend Per Share

0

Dividend Yield

0

EPS

-1.245

Quarterly Earnings Growth YOY

-0.926

Quarterly Revenue Growth YOY

0.447

Trailing PE

-

Forward PE

-

EV To Revenue

2.483

EV To EBITDA

11562.57

52 Week High

78.92

52 Week Low

17.01

50 Day Moving Average

33.96

200 Day Moving Average

49.65

Shares Outstanding

26249900

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

Castle Biosciences stock forecast for this year


Castle Biosciences stock forecast for Jan 2024.
Estimated Average Forecasted Castle Biosciences Price: 27.42. Positive monthly dynamics of the instrument is expected with 6.222% volatility is expected.

Pessimistic forecast: 26.61

Optimistic: 28.38


Castle Biosciences stock forecast for Feb 2024.
Estimated Average Forecasted Castle Biosciences Price: 26.65. Negative monthly dynamics of the instrument is expected with 11.534% volatility is expected.

Pessimistic forecast: 25.76

Optimistic: 29.11


Castle Biosciences stock forecast for Mar 2024.
Estimated Average Forecasted Castle Biosciences Price: 25.79. Negative monthly dynamics of the instrument is expected with 17.641% volatility is expected.

Pessimistic forecast: 23.27

Optimistic: 28.25


Castle Biosciences stock forecast for Apr 2024.
Estimated Average Forecasted Castle Biosciences Price: 27.45. Positive monthly dynamics of the instrument is expected with 8.773% volatility is expected.

Pessimistic forecast: 26.38

Optimistic: 28.91


Castle Biosciences stock forecast for May 2024.
Estimated Average Forecasted Castle Biosciences Price: 31.11. Positive monthly dynamics of the instrument is expected with 9.609% volatility is expected.

Pessimistic forecast: 29.49

Optimistic: 32.63


Castle Biosciences stock forecast for Jun 2024.
Estimated Average Forecasted Castle Biosciences Price: 33.24. Positive monthly dynamics of the instrument is expected with 10.280% volatility is expected.

Pessimistic forecast: 30.87

Optimistic: 34.40


Castle Biosciences stock forecast for Jul 2024.
Estimated Average Forecasted Castle Biosciences Price: 35.01. Positive monthly dynamics of the instrument is expected with 15.804% volatility is expected.

Pessimistic forecast: 31.33

Optimistic: 37.21


Castle Biosciences stock forecast for Aug 2024.
Estimated Average Forecasted Castle Biosciences Price: 33.24. Negative monthly dynamics of the instrument is expected with 15.108% volatility is expected.

Pessimistic forecast: 31.38

Optimistic: 36.97


Castle Biosciences stock forecast for Sep 2024.
Estimated Average Forecasted Castle Biosciences Price: 35.06. Positive monthly dynamics of the instrument is expected with 15.194% volatility is expected.

Pessimistic forecast: 31.23

Optimistic: 36.83


Castle Biosciences stock forecast for Oct 2024.
Estimated Average Forecasted Castle Biosciences Price: 37.12. Positive monthly dynamics of the instrument is expected with 14.354% volatility is expected.

Pessimistic forecast: 34.73

Optimistic: 40.55


Castle Biosciences stock forecast for Nov 2024.
Estimated Average Forecasted Castle Biosciences Price: 34.26. Negative monthly dynamics of the instrument is expected with 16.321% volatility is expected.

Pessimistic forecast: 31.48

Optimistic: 37.62


Castle Biosciences stock forecast for Dec 2024.
Estimated Average Forecasted Castle Biosciences Price: 35.70. Positive monthly dynamics of the instrument is expected with 17.474% volatility is expected.

Pessimistic forecast: 32.10

Optimistic: 38.90



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 109.88 (13.05.2022) 1.77 %
AbbVie Inc.
ABBV 153.5 (13.05.2022) -0.51 %
Aeterna Zentaris Inc.
AEZS 0.2451 (13.05.2022) 4.08 %
Allakos Inc.
ALLK 3.24 (13.05.2022) 4.18 %
Allogene Therapeutics, Inc.
ALLO 7.23 (13.05.2022) 3.73 %
Amgen Inc.
AMGN 243.4 (13.05.2022) -0.54 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 5.48 (13.05.2022) 4.98 %
Aurora Cannabis Inc.
ACB 2.84 (13.05.2022) 17.36 %
Becton Dickinson and Company
BDX 248.44 (13.05.2022) -0.51 %
Biogen Inc.
BIIB 198.38 (16.05.2022) -0.37 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 141 (13.05.2022) 0.28 %
BioNTech SE
BNTX 158.84 (13.05.2022) 0.53 %
bluebird bio, Inc.
BLUE 3.57 (13.05.2022) 5.93 %
Boston Scientific Corp.
BSX 39.66 (13.05.2022) 2.24 %
Bristol-Myers Squibb Company
BMY 76.91 (16.05.2022) 1.46 %
Canopy Growth Corp.
CGC 5.92 (13.05.2022) 10.24 %
Castle Biosciences, Inc.
CSTL 19.71 (13.05.2022) 3.90 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 3.16 (07.01.2022) -5.67 %
Eli Lilly and Company
LLY 242.27 (04.02.2022) 0.00 %
Emergent BioSolutions Inc.
EBS 28.74 (13.05.2022) -1.17 %
Exelixis, Inc.
EXEL 20.26 (16.05.2022) 0.90 %
G1 Therapeutics, Inc.
GTHX 4.61 (13.05.2022) -0.65 %
Gilead Sciences, Inc.
GILD 62.37 (13.05.2022) -0.18 %
GlaxoSmithKline plc
GSK 43.32 (13.05.2022) 2.00 %
GoodRx Holdings, Inc.
GDRX 8.9 (13.05.2022) 10.70 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 74.51 (16.05.2022) -0.52 %
Inovio Pharmaceuticals, Inc.
INO 1.89 (16.05.2022) -5.03 %
Johnson & Johnson
JNJ 178.08 (16.05.2022) 0.70 %
Medtronic plc.
MDT 102.67 (13.05.2022) 1.54 %
Merck & Co., Inc.
MRK 92.32 (16.05.2022) 2.11 %
Moderna, Inc.
MRNA 137.91 (13.05.2022) 5.95 %
Novartis AG
NVS 85.82 (13.05.2022) 0.52 %
Novavax, Inc.
NVAX 51.89 (13.05.2022) 8.15 %
ObsEva SA
OBSV 1.48 (13.05.2022) 8.82 %
OrganiGram Holdings Inc.
OGI 1.28 (16.05.2022) 4.07 %
Pfizer Inc.
PFE 49.92 (13.05.2022) -0.93 %
Regeneron Pharmaceuticals, Inc.
REGN 655.01 (16.05.2022) 1.47 %
Sanofi
SNY 52.03 (13.05.2022) 1.58 %
Schrodinger, Inc.
SDGR 24.57 (13.05.2022) 9.25 %
Senseonics Holdings, Inc.
SENS 1.13 (13.05.2022) 11.88 %
Sorrento Therapeutics, Inc.
SRNE 1.43 (13.05.2022) 10.00 %
Stryker Corp.
SYK 233.27 (13.05.2022) 2.31 %
Sundial Growers Inc.
SNDL 0.465 (16.05.2022) 21.09 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 7.76 (13.05.2022) 3.33 %
Thermo Fisher Scientific Inc.
TMO 541.42 (13.05.2022) 2.97 %
Tilray, Inc.
TLRY 4.88 (16.05.2022) 7.49 %
UnitedHealth Group, Inc.
UNH 485.4 (13.05.2022) 1.38 %
Veeva Systems Inc.
VEEV 172.78 (13.05.2022) 5.26 %
Zomedica Corp.
ZOM 0.2204 (13.05.2022) 10.14 %
Zynerba Pharmaceuticals, Inc.
ZYNE 0.8557 (13.05.2022) -4.92 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.